Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylene Chloride SCHEMBL1159353 | 1.00 | ALDH1A1 (0.33) | ALDH1A1 | |
| Methylene Chloride SCHEMBL7421886 | 1.00 | ALDH1A1 (0.33) | ALDH1A1 | |
| Methylene Chloride SCHEMBL7249214 | 1.00 | ALDH1A1 (0.33) | ALDH1A1 | |
| Methylene Chloride SCHEMBL4264211 | 1.00 | ALDH1A1 (0.33) | ALDH1A1 | |
| Methylene Chloride SCHEMBL565915 | 1.00 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL1982189 | 0.91 | — | — | |
| Methane SCHEMBL10705120 | 0.87 | MEN1 (0.31) | — | |
| SCHEMBL9065354 | 0.80 | — | — | |
| SCHEMBL7598389 | 0.74 | TP53 (0.33) | — | |
| Methylene Chloride SCHEMBL28765651 | 0.70 | ALDH1A1 (0.44) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 682 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115210287-B | Epoxy amine adduct, curing catalyst, resin composition, sealing material, adhesive, and cured product | 纳美仕有限公司 | 2024-07-02 | — | — | CN | disclosed |
| US-20240197923-A1 | IMIDAZOPYRAZINE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, AND THEIR USES AS LUCIFERINS | INSTITUT PASTEUR (FR) | 2024-06-20 | — | — | US | disclosed |
| WO-2024126617-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING KINASES VIA UBIQUITIN PROTEOSOME PATHWAY | CROSSFIRE ONCOLOGY HOLDING B.V. (NL) | 2024-06-20 | — | — | WO | disclosed |
| US-20240132519-A1 | NRF2-ACTIVATING COMPOUND | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2024-04-25 | — | — | US | disclosed |
| CN-115003727-B | Curing catalyst, resin composition, sealing material, adhesive and cured product | 纳美仕有限公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-4328586-A1 | FLUORESCENT STAINING METHOD | OSAKA UNIVERSITY (JP) | 2024-02-28 | — | — | EP | disclosed |
| EP-3354639-B1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2024-02-21 | — | — | EP | disclosed |
| CN-117480390-A | Fluorescent staining method | 国立大学法人大阪大学 | 2024-01-30 | — | — | CN | disclosed |
| EP-4308570-A1 | MACROCYCLIC LRRK2 KINASE INHIBITORS | Les Laboratoires Servier (FR) | 2024-01-24 | — | — | EP | disclosed |
| CN-117425661-A | Macrocyclic LRRK2 kinase inhibitors | 法国施维雅药厂 | 2024-01-19 | — | — | CN | disclosed |
| EP-0302792-A2 | Alkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same | SANOFI (FR) | 1989-02-08 | — | — | EP | disclosed |
| EP-0292820-A2 | 3-Phenyl-2-styryl-pyrrolidines, their preparation and use | BASF Aktiengesellschaft (DE) | 1988-11-30 | — | — | EP | disclosed |
| EP-0292819-A2 | 5-Phenyl-1,2,3a,4,5,9b-hexahydro-3H-benz[e]indoles, their preparation and use as medicaments | BASF Aktiengesellschaft (DE) | 1988-11-30 | — | — | EP | disclosed |
| EP-0172059-B1 | DERIVATIVES OF OXAAZAPHOSPHORINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ADIR (FR) | 1988-04-20 | — | — | EP | disclosed |
| EP-0217700-A1 | Benzimidazole derivatives, their preparation and their therapeutical use | SYNTHELABO (FR) | 1987-04-08 | — | — | EP | disclosed |
| EP-0172059-A1 | Derivatives of oxaazaphosphorine, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1986-02-19 | — | — | EP | disclosed |
| EP-0056866-B1 | PHENYLPIPERAZINE DERIVATIVES OF HETERYLPHENOLS AND HETARYLANILINES, THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS | BASF Aktiengesellschaft (DE) | 1985-06-19 | — | — | EP | disclosed |
| EP-0019172-B1 | 6-SUBSTITUTED 11-ALKYLENE-MORPHANTRIDINES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1983-07-13 | — | — | EP | disclosed |
| EP-0019172-A1 | 6-Substituted 11-alkylene-morphantridines, process for preparing them and pharmaceutical compositions containing them | BASF Aktiengesellschaft (DE) | 1980-11-26 | — | — | EP | disclosed |
| EP-0019157-A1 | 5,6-Dihydro-11-alkylene-morphanthridin-6-ones and process for their preparation | BASF Aktiengesellschaft (DE) | 1980-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240197923-A1 | IMIDAZOPYRAZINE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, AND THEIR USES AS LUCIFERINS | NISCH, HLCS, CYP3A5 | ALDH1A1 972/4885 |
| US-20240132519-A1 | NRF2-ACTIVATING COMPOUND | NFE2L2, KEAP1, NFE2 | ALDH1A1 756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.